Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$50.75 – $61.84
0% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.43B | $1.52B | $1.43B | $1.68B | $1.76B | $1.97B | $2.26B | $2.43B |
| Cost of revenue | $288.1M | $305.7M | $282.2M | $340.6M | $379.5M | $395.7M | $452.4M | $1.78B |
| Gross profit | $1.14B | $1.22B | $1.15B | $1.34B | $1.38B | $1.57B | $1.81B | $655.9M |
| Gross margin | 79.8% | 79.9% | 80.3% | 79.7% | 78.4% | 79.9% | 80.0% | 26.9% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $249.9M | $257.3M | $179.2M | $583.6M | $575.6M | $648.8M | $341.7M | $323.4M |
| EBITDA | $295.8M | $385.2M | $328.7M | $278.9M | $347.0M | $409.9M | $475.7M | $553.1M |
| Net income | $168.9M | $172.2M | $116.4M | $136.9M | $103.7M | $124.8M | $152.1M | $203.7M |
| Net margin | 11.8% | 11.3% | 8.1% | 8.2% | 5.9% | 6.3% | 6.7% | 8.4% |
| EPS (diluted) | 2.01 | 2.05 | 1.39 | 1.63 | 1.23 | 1.49 | 1.81 | 2.43 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $2.6B | $2.63 | $2.56–$2.69 | 6 |
| 2027 | $2.7B | $2.94 | $2.87–$3.01 | 6 |
| 2028 | $2.8B | $3.28 | $3.21–$3.36 | 7 |
| 2029 | $3.0B | $3.31 | $3.23–$3.39 | 6 |
Forward consensus · source: Financial Modeling Prep
FIELMANN GROUP AG
No one on the platform currently holds FLMNF.
No tracked institution reports a position in FLMNF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-07-13 | $1.4000 | 2026-07-14 |
| 2025-07-14 | $1.1500 | 2025-07-15 |
| 2024-07-15 | $1.0000 | 2024-07-16 |
| 2023-07-14 | $0.7500 | 2023-07-18 |
| Execution date | Ratio |
|---|---|
| 2006-08-09 | 2-for-1 |
No one on the platform has traded FLMNF yet.
| $5.3B |
| — |
| CNVVYConvaTec Group Plc | $11.47 | +1.77% | $5.6B | — |
| CZMWFCarl Zeiss Meditec AG | $30.00 | +0.00% | $2.6B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 28.0× earnings vs its 28.3× historical median P/E.
Fair value ≈ $51.27 · price $50.75 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.